Vancouver, British Columbia, Canada – February 1, 2018 – Namaste Technologies Inc. (CSE:N)(Frankfurt: M5BQ) (OTCMKTS: NXTTF) (“Namaste” or the “Company”), is pleased to announce that it has entered…
Read More
Vancouver, British Columbia, February 1, 2018 – Hemisphere Energy Corporation (TSX-V: HME) ("Hemisphere" or the "Company") is pleased to announce an increase to its term loan and…
Read More
VANCOUVER, BC / February 1, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) announces the launch of their Pre-Pivotal Trial clinical…
Read More
VANCOUVER, BC / ACCESSWIRE / January 30, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces that it intends to…
Read More
VANCOUVER, January 31, 2018 – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated…
Read More
VICTORIA, BC and VANCOUVER, BC, January, 30, 2018 – Emerald Health Therapeutics Inc. (“Emerald”) (TSXV:EMH) (OTCQX:EMHTF) and Namaste Technologies Inc. (“Namaste”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) have signed a Letter…
Read More
Vancouver, British Columbia, Canada - Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N), (FRANKFURT: M5BQ), (OTCMKTS: NXTTF) is pleased to announce the filing of its unaudited quarterly financial…
Read More
Vancouver – Wednesday, January 24, 2018 – CRYSTAL EXPLORATION INC. (the “Company” and “Crystal”) (TSXV: “CEI”) (OTCQB: “CYRTF”) is pleased to announce that two new mineral claims have…
Read More
VANCOUVER, BC / January 23, 2018 / CVR Medical Corp. (TSX.V: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the commencement of clinical data acquisition by the…
Read More
VANCOUVER, British Columbia, Jan. 22, 2018 (GLOBE NEWSWIRE) — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that Health Canada’s Office…
Read More